Galmed Pharmaceuticals Ltd. buy Roth Mkm
Start price
20.10.23
/
50%
€0.39
Target price
20.10.24
€70.85
Performance (%)
1558.03%
Price
19.09.24
€6.40
Summary
This prediction is currently active. The BUY prediction by Roth_Mkm for Galmed Pharmaceuticals Ltd. has seen massive gains of 1558.03%. This prediction currently runs until 20.10.24. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Roth_Mkm for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for GMED provided by MarketBeat